DRKS00022211招募中不适用
Investigation of complement activation and autoantibody formation in lysosomal storage diseases: Fabry disease and Gaucher's disease - Complement in LSDs
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- eleva GmbH
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Patients with Fabry disease (male) with Lyso-Gb3 value of >0.5 nmol/l, which are treatment-naive or recieve a enzyme replacement therapy (Replagal or Fabrazyme).
- •Patients with Gaucher disease type I (male and female), which are treatment-naive or recieve a enzyme replacement therapy (Cerezyme, VPRIV or Elelyso).
排除标准
- •Excluded from the study are patients with chronic inflammatory diseases associated with the complement system, such as systemic lupus erythematosus (SLE), sepsis or ANCA-associated vasculitis, as well as patients with a bacterial or viral infection.
- •Patients who have been administered another form of therapy prior to ERT.
研究者
相似试验
已完成
不适用
Investigation of complement activity between generic drug and barand-name drug for the use of anticoagulant during blood apheresis therapySepsisJPRN-UMIN000029038Shiga University of Medical Science50
进行中（未招募）
1 期
A Phase I Clinical Study of VSA012 in Healthy VolunteersHealthy VolunteersNCT06766929Bisirna Therapeutics (Suzhou) Co., Ltd.40
尚未招募
1 期
Effect of Tripterygium wilfordii polyglycoside tablets on the inhibition of TM on complement pathway and related inflammatory markers in membranous nephropathyidiopathic membranous nephropathyITMCTR2000003816onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
招募中
不适用
Study for protein expression of the complement activation product C4a in patient plasma of non-small cell lung cancer of different clinical stagesnon-small cell lung cancerITMCTR1900002409Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine
尚未招募
不适用
Identification of complement inhibitors and complement regulatory proteins in ABO-incompatible compare with HLA-incompatible kidney transplantatioABOi kidney transplantationHLAi kidney transplantationAccommodationABO incompatibility or ABO incompatible kidney transplantationComplement regulatory proteinsComplement inhibitorsHLA incompatibility or HLA incompatible kidney transplantationKidney transplantationTCTR20210904002/A30